Pharmacokinetic Analysis of Octa-α-butyloxy-Zinc Phthalocyanine in Mice Bearing Lewis Lung Carcinoma
Authors:
- Cathrin DresslerCDCathrin Dressler
- Peter KoeppePKPeter Koeppe
- Rainer G. SenzRSRainer G. Senz
- Beate RöderBRBeate Röder
- Hans WeitzelHWHans Weitzel
- Hans-Peter BerlienHBHans-Peter Berlien
- 1 January 1997
- journal article
- research article
- Published by SAGE Publications in Journal of Clinical Laser Medicine & Surgery
- Vol. 15 (4) , 157-161
Abstract
In this study, the pharmacokinetics of octa-alpha-butyloxy-zinc phthalocyanine (8-alpha-bo-ZnPc) was studied with regard to Lewis lung carcinoma in mice after intravenous administration of 7.8 mumole/kg body weight at different incubation intervals. The newly synthesized potential photosensitizer 8-alpha-bo-ZnPc is characterized by a high absorption coefficient at the far red wavelength (735 nm) with a good singlet oxygen quantum yield. After intravenous administration of 7.8 mumole/kg body weight in mice bearing Lewis lung carcinoma, the accumulated photosensitizer was chemically extracted (at incubation intervals of 2, 6, 12, 24, 48, and 168 hours) from selected tissues, and the concentrations were measured by absorption spectroscopy. The parenchymatous organs, liver, and spleen showed maximum 8-alpha-bo-ZnPc concentrations after 6 hours of incubation. An extensive uptake was detected in lung extracts taken at 6, 12, 24, and 48 hours. The malignant tissue did not accumulate high 8-alpha-bo-ZnPc during the entire investigation period. The photosensitizer extracted from muscle, representing normal tumor-surrounding tissue and skin, was even lower. Because of the extremely low accumulation rate of the tumor, 8-alpha-bo-ZnPc is suggested to be administered topically or in combination with a suitable carrier system in order to increase the photosensitizer concentration in the target tissue, as well as to decrease the loss of dye to other tissues.Keywords
This publication has 12 references indexed in Scilit:
- Selectivity ofmeso-tetra(hydroxyphenyl)porphyrins and chlorins and of photofrin II in causing photodamage in tumour, skin, muscle and bladder. The comcept of cost-benefit in analysing the resultsLasers in Medical Science, 1993
- Quantification of phthalocyanine concentration in rat tissue using laser–induced fluorescence spectroscopyLasers in Surgery and Medicine, 1993
- Photocytotoxic efficacy of sulphonated species of aluminium phthalocyanine against cell monolayers, multicellular spheroids and in vivo tumoursBritish Journal of Cancer, 1991
- CARBOXYLATED ZINC‐PHTHALOCYANINES–II* DIMERIZATION AND SINGLET MOLECULAR OXYGEN SENSITIZATION IN HEXADECYLTRIMETHYLAMMONIUM BROMIDE MICELLESPhotochemistry and Photobiology, 1991
- COMPARISON OF DISTRIBUTION AND PHOTODYNAMIC EFFECTS OF DI- AND TETRA-SULPHONATED ALUMINIUM PHTHALOCYANINES IN NORMAL RAT COLONPhotochemistry and Photobiology, 1991
- PHTHALOCYANINES AS PHOTODYNAMIC SENSITIZERS*Photochemistry and Photobiology, 1991
- A COMPARISON OF FLUORESCENCE METHODS USED IN THE PHARMACOKINETIC STUDIES OF Zn(II)PHTHALOCYANINE IN MICEPhotochemistry and Photobiology, 1991
- Photophysical properties and photodynamic activity in vivo of some tetrapyrrolesBiophysical Chemistry, 1990
- CYTOTOXIC AND MUTAGENIC EFFECTS OF THE PHOTODYNAMIC ACTION OF CHLOROALUMINUM PHTHALOCYANINE AND VISIBLE LIGHT IN L5178Y CELLSPhotochemistry and Photobiology, 1989
- Photodynamic therapy with phthalocyanine sensitisation: quantitative studies in a transplantable rat fibrosarcomaBritish Journal of Cancer, 1987